Načítá se...
A Review of mTOR Pathway Inhibitors in Gynecologic Cancer
The treatment of advanced gynecologic cancers remains palliative in most of cases. Although systemic treatment has entered into the era of targeted drugs the antitumor efficacies of current therapies are still limited. In this context there is a great need for more active treatment and rationally de...
Uloženo v:
| Vydáno v: | Oxid Med Cell Longev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327776/ https://ncbi.nlm.nih.gov/pubmed/28286604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4809751 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|